Whitepaper

The Changing face of Consumer Healthcare during COVID-19
Resetting the Consumer Healthcare market for the new normal
Consumer Healthcare during COVID-19

More Whitepapers / Newsletters

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in ar...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...

HIV-Associated Lipodystrophy Market
HIV-Associated Lipodystrophy

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cau...

Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy...

Progressive Supranuclear Palsy (PSP) is a rare progressive disorder resulting from damage that occurs in brain cells over time. It causes problems with balance, speech, swallowing, movement, and visio...

Emergence of E-Pharmacies Whitepaper
Emergence of E-Pharmacies: Cha...

In the past few years, online buying has become the easiest way to purchase products and services. The ever increasing users of the internet services have led to the blooming of the e-commerce sector...